Impact of branched-chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study
详细信息 查看全文
- 作者：Kazuho Imanaka ; Kazuyoshi Ohkawa ; Tomohide Tatsumi ; Kazuhiro Katayama ; Atsuo Inoue ; Yasuharu Imai ; Masahide Oshita ; Sadaharu Iio ; Eiji Mita ; Hiroyuki Fukui ; Akira Yamada ; Fumihiko Nakanishi ; Masami Inada ; Yoshinori Doi ; Kunio Suzuki ; Akira Kaneko ; Shigeru Marubashi ; Yuri Ito ; Keisuke Fukui ; Ryotaro Sakamori ; Takayuki Yakushijin ; Naoki Hiramatsu ; Norio Hayashi ; Tetsuo Takehara and the Osaka Liver Forum
- 刊名：Hepatology Research
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：46
- 期：10
- 页码：1002-1010
- 全文大小：294K
- ISSN：1872-034X
文摘
The therapeutic efficacy of branched-chain amino acid (BCAA) when added to sorafenib has not been fully assessed in patients with advanced hepatocellular carcinoma (HCC). This multicenter study investigated whether BCAA supplementation improves prognosis in patients with advanced HCC who underwent sorafenib treatment.